| Literature DB >> 32799979 |
Jocelyn E Remmert1, Adam G Tsai2, Savannah R Roberts1, Meghan L Butryn1.
Abstract
Primary care physicians can play a key role in supporting patients after behavioural weight loss, though little is known about communication between patients and physicians during this time. Adults (n=139) in a behavioural weight loss trial (delivered outside of primary care) who attended a primary care appointment after an initial weight loss period were surveyed to assess weight-related communication at their most recent appointment. Most participants (78%) reported discussing weight with their physician. Participants who discussed weight, compared to those who did not, lost more weight, had higher blood pressure, and were more likely to be male. Most (89%) reported that their physician was supportive of their weight loss, but only a few participants (6.9%) reported that their physician gave feedback on medical parameters. Areas for improvement identified include physicians providing universal support for modest weight changes and providing interpretation of medical measurements that changed due to weight loss.Entities:
Keywords: lifestyle modification; obesity; primary care
Mesh:
Year: 2019 PMID: 32799979 PMCID: PMC8060814 DOI: 10.1017/S1463423619000124
Source DB: PubMed Journal: Prim Health Care Res Dev ISSN: 1463-4236 Impact factor: 1.458
Figure 1Participant flow from parent behavioural weight loss trial to current study of 139 behavioural weight loss participants who have attended an appointment with their primary care physician in the past 12 months
Demographics of 139 behavioural weight loss participants
| Characteristic | Measure ( |
|---|---|
| Age in years, mean (SD) | 54.9 (9.7) |
| Gender | |
| Female, | 98 (70.5%) |
| Male, | 41 (29.5%) |
| Race | |
| White, | 97 (69.8%) |
| Asian, | 1 (0.7%) |
| Black or African American, | 36 (25.9%) |
| More than one race, | 5 (3.6%) |
| Percent weight loss at post-treatment (18 months), mean (SD) | 11.9% (10.7%) |
| Months between last PCP appointment and 18-month assessment, mean (SD) | 4.2 (3.2) |
| Reasons for last appointment with PCP | |
| Regular check-up, | 103 (74.1%) |
| Sick/injury visit, | 22 (15.8%) |
| Form signed, | 6 (4.3%) |
| Other, | 8 (5.8%) |
PCP=primary care physician
Owing to low percentage of non-White participants, race was dichotomized for analyses into participants that identified as White or non-White (ie, all other races and more than one race)
Comparisons between participants discussed weight with their primary care physician and participants who did not discuss weight during weight loss maintenance in 139 behavioural weight loss participants
| Measure | Discuss weight | Did not discuss weight | Test statistic | Significance ( | Effect size (Cohen’s |
|---|---|---|---|---|---|
| Demographics | |||||
| Age (years) | 55.0 (9.5) | 54.3 (10.3) |
| 0.70 | 0.07 |
| Gender |
| 0.008** | 0.22 | ||
| Male | 38 (34.9%) | 3 (10%) | |||
| Female | 71 (65.1%) | 27 (90%) | |||
| Race |
| 0.19 | 0.11 | ||
| White | 79 (72.5%) | 18 (60%) | |||
| Non-White | 30 (27.5%) | 12 (40%) | |||
| Socioeconomic status |
| 0.025* | 0.29 | ||
| $0–50,000 | 13 (12.5%) | 4 (13.8%) | |||
| $50,001–100,000 | 31 (29.5%) | 17 (58.6%) | |||
| $100,001–150,000 | 29 (27.6%) | 6 (20.7%) | |||
| $150,000–200,000 | 20 (19.0%) | 2 (6.9%) | |||
| $200,001 and up | 12 (11.4%) | 0 (0%) | |||
| Health measures | |||||
| BL number of comorbidities | 2.9 (2.1) | 2.4 (2.4) |
| 0.30 | 0.22 |
| BL blood pressure |
| 0.93 | 0.08 | ||
| Normal range | 31 (28.4%) | 7 (24.1%) | |||
| Elevated range | 6 (5.5%) | 2 (9.9%) | |||
| Stage 1 | 34 (31.2%) | 10 (34.5%) | |||
| Stage 2 | 36 (33%) | 10 (34.5%) | |||
| Hypertensive crisis range | 2 (1.8%) | 0 (0%) | |||
| Percent weight loss BL to 6 months | 11.3% (5.3) | 7.9% (4.9) |
| 0.002** | 0.67 |
| Percent weight loss BL to 18 months | 12.9% (10.6) | 8.4% (10.7) |
| 0.045* | 0.42 |
| Change in resting heart rate BL to 18 months (beats/minute) | −4.8 (11.0) | −2.2 (13.2) |
| 0.26 | 0.22 |
| Change in waist circumference BL to 18 months (inches) | −4.2 (4.5) | −1.8 (3.6) |
| 0.008** | 0.59 |
| Change in BMI BL to 18 months | −4.6 (4.0) | −3.2 (4.4) |
| 0.10 | 0.33 |
| 18 months BMI | 30.1 (5.3) | 31.1 (4.6) |
| 0.35 | 0.20 |
| 18 months Resting heart rate (beats/minute) | 69.9 (11.3) | 71.4 (11.3) |
| 0.53 | 0.13 |
| 18 months Blood pressure |
| 0.018* | 0.27 | ||
| Normal range | 35 (32.1%) | 17 (56.7%) | |||
| Elevated range | 13 (11.9%) | 6 (20%) | |||
| Stage 1 | 34 (31.2%) | 4 (13.3%) | |||
| Stage 2 | 27 (24.8%) | 3 (10%) | |||
| Hypertensive crisis range | 0 (0%) | 0 (0%) |
*Significance at P<0.05. **Significance at P<0.01. BL=Baseline
n=109
n=30
n=105 discuss weight (n=4 missing data); n=29 did not discuss weight (n=1 missing data)
Sum of comorbidities endorsed at baseline (heart disease, angina, palpitations, stroke, rheumatic fever, heart murmur, pacemaker, breathing problems [asthma, lung disease], high blood pressure, anaemia, back problems, joint or bone problems, hiatal hernia, arthritis, gout, gallbladder disease, thyroid problems, kidney disease, ulcers, bowel disease, liver disease, diabetes [type I or II], sleep apnoea, bodily pain, other)
n=138; n=1 missing data
Blood pressure categories calculated according to the American Heart Association guidelines
Qualitative results from 18 behavioural weight loss participants describing their most recent weight-related communication with their primary care physician
| Theme |
| Quotes (participant characteristics during 18-month behavioural weight loss trial) |
|---|---|---|
| PCP provided enthusiastic support (beyond providing general encouragement) | 4 | ‘She is thrilled with my progress’ (Female, lost 14.7% of weight, blood pressure dropped from the elevated range to normal range over course of study, 18-month BMI of 29.3) ‘Thought I had really accomplished a great feat!’ (Female, lost 17.8% of weight, blood pressure dropped from the elevated range to normal range from baseline to 18-month, 18 months BMI of 23.50) |
| PCP indicated that they were unsupportive of the patient’s changes/weight loss | 4 | ‘I brag[ged] about all the weight I lost with Project Impact (the research study), she told me I was obese.’ (Female, lost 12.3% of weight, blood pressure in Stage 1 range at baseline and 18 months, 18-month BMI of 32.7) |
| PCP and patient noted a gain from the last appointment | 3 | ‘I gained weight [since my last appointment]. She encouraged me to continue with Project Impacta.’ (Female, lost 13.3% of weight, blood pressure at stage 1 at baseline and 18 months, 18-month BMI of 28.0) |
| PCP and patient discussed specific medical parameters changing | 3 | ‘[Discussed] Cholesterol level’ (Male, lost 15% of weight, blood pressure dropped from the elevated to normal range from baseline to 18 months, 18-month BMI of 30.6) |
| PCP and patient discussed specific strategies to lose weight | 2 | ‘A bit of a combination. He suggested specific diet books to read, discussed (the research study)a and the main tenets of the program, suggested exercise strategies’ (Male, gained 2.6% of weight, blood pressure increased from normal to stage 1 range from baseline to 18 months, 18-month BMI of 44.8) |
PCP=primary care physician; BMI=body mass index
Weight and blood pressure listed above measured at 18-month study assessment, not at PCP appointment